MCM
AEON icon

MAI Capital Management’s AEON Biopharma AEON Stock Holding History

MAI Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58
Closed -$58 – 2151
2026
Q1 		$58 Hold
58
– – ﹤0.01% 4846
2025
Q4 		$64 Hold
58
– – ﹤0.01% 4210
2025
Q3 		$47 Hold
58
– – ﹤0.01% 3764
2025
Q2 		$45 Hold
58
– – ﹤0.01% 3917
2025
Q1 		$34 Sell
58
-1
-2% -$7 ﹤0.01% 3397
2024
Q4 		$2.29K Buy
+59
New +$3.44K ﹤0.01% 2999

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAI Capital Management's AEON Position: Q2 2026 in Review

MAI Capital Management sold out of AEON Biopharma (AEON) in Q2 2026, closing a stake of 58 shares — an estimated $58 sold.

MAI Capital Management first reported a position in AEON in Q4 2024 and held it in 6 quarters. The position peaked at $2.29K in Q4 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • MAI Capital Management reported no remaining AEON Biopharma position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 58 AEON Biopharma shares in Q2 2026, an estimated $58.
  • MAI Capital Management first reported a position in AEON Biopharma in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's AEON Biopharma position peaked at $2.29K in Q4 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.